Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure.
Yuichiro ShindoYasuhiro KondohAkiko KadaYohei DoiKeisuke TomiiHiroshi MukaeNaohiko MurataRyosuke ImaiMasaki OkamotoYasuhiko YamanoYasunari MiyazakiMasahiro ShinodaHiromichi AsoShinyu IzumiHaruyuki IshiiRyota ItoAkiko M SaitoToshiki I SaitoYoshinori HasegawaPublished in: Infectious diseases and therapy (2021)
Japan Registry of Clinical Trials (jRCT) identifier jRCTs041200025.
Keyphrases
- combination therapy
- phase ii
- respiratory failure
- clinical trial
- coronavirus disease
- sars cov
- extracorporeal membrane oxygenation
- mechanical ventilation
- open label
- high dose
- double blind
- phase iii
- acute respiratory distress syndrome
- study protocol
- intensive care unit
- respiratory syndrome coronavirus
- randomized controlled trial
- placebo controlled